{"url_path":"/sec/imux/8-k/2026-05-13/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1280776/0001193805-26-000593-index.html","accession_number":"0001193805-26-000593","cik":"0001280776","ticker":"IMUX","issuer_name":"IMMUNIC, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1280776/0001193805-26-000593-index.html","primary_entity_key":"0001280776","primary_entity_name":"IMMUNIC, INC."},"word_count":76,"has_tables":true,"body_markdown":"**Item 9.01. Financial Statements and Exhibits**\n\n \n\n**Exhibit**\n**Description**\n\n \n \n\n99.1\n[Press Release, dated May 13, 2026.](e665461_ex99-1.htm)\n\n104\nCover Page to this Current Report on Form 8-K in Inline XBRL.\n\n \n\n \n\n \n\n \n\n**SIGNATURES**\n\n** **\n\nPursuant to the requirements of the Securities Exchange Act of 1934,\nas amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.\n\n \n\nDated:  May 13, 2026\n**Immunic, Inc.**\n\n \n \n \n\n \nBy:\n*/s/ Daniel Vitt*\n\n \n \nDaniel Vitt\n\n \n \nChief Executive Officer"}